Pharmaceutical Intermediates - Commercial Products
S.No |
NAME OF INTERMEDIATE | CAS NUMBER | API Application |
---|---|---|---|
1 |
6-Iodoquinazolin-4(3H)-one | 16064-08-7 | Lapatinib |
2 |
4-(3-Chloropropyl)morpholine | 7357-67-7 | Gefitanib |
3 |
Methyl-3-hydroxy-4-methoxybenzoate | 6702-50-7 | Gefitanib |
4 |
Methyl-5-hydroxy-4-methoxy-2-nitrobenzoate | 215659-03-3 | Gefitanib |
5 |
5-hydroxy-4-methoxy-2-nitrobenzoic acid ethyl ester | 1146162-38-0 | Gefitanib |
6 |
(S)-2((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamido)-3-phenylpropanoic acid | 868540-16-3 | Carfilzomib |
7 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2- pyrimidineamine | 152460-10-1 | Imatinib |
8 |
4-(4-Methylpiperzinomethyl)benzoic acid.2HCl | 106261-49-8 | Imatinib |
9 |
4-Phenoxybenzoic acid | 2215-77-2 | Ibrutanib |
10 |
3-Iodo-4-methylbenzoic acid | 82998-57-0 | Ponatinib |
11 |
Methyl-4-amino-2-methoxybenzoate | 27492-84-8 | Lenvatinib |
12 |
4-Amino-2-chlorobenzonitrile | 20925-27-3 | Lenvatinib |
13 |
4-Phenylthiopyrrolidine-2-carboxylic acid | 105107-84-4 | Zofinopril |
14 |
5-Amino-2,4-ditertiarybutylphenol | 873055-58-4 | Ivacaftor |
15 |
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid | 13721-01-2 | Ivacaftor |
16 |
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester | 52980-28-6 | Ivacaftor |
17 |
5-Bromo-2-chlorobenzoic acid | 21739-92-4 | Dapagliflozin |
18 |
4-(5-Bromo-2-chlorobenzyl)phenylethyl ether | 461432-23-5 | Dapagliflozin |
19 |
2-Chloro-5-iodobenzoic acid | 19094-56-5 | Empagliflozin |
20 |
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone | 915095-86-2 | Empagliflozin |
21 |
(5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone | 915095-85-1 | Empagliflozin |
22 |
4-(5-Bromo-2-chlorobenzyl)phenol | 864070-18-8 | Empagliflozin |
23 |
(S)-3-(2-(5-Bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 2744280-76-8 | Empagliflozin |
24 |
5-Bromo-2-methylbenzoic acid | 79669-49-1 | Canagliflozin |
25 |
5-Iodo-2-methylbenzoic acid | 54811-38-0 | Canagliflozin |
26 |
(5-Bromo-4-methoxy-2-methylbenzyl)phenylethyl ether | Luseogliflozin | |
27 |
1-(2-Chloroacetyl)-pyrrolidine-(2S)-carbonitrile | 207557-35-5 | Vildagliptin |
28 |
(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]-acetyl] -pyrrolidin-2-carbonitrile |
274901-16-5 | Vildagliptin |
29 |
Sodium-5-(methoxycarbonyl)-6-oxo-1,2,3,6-tetrahydropyridin-4-olate | 198213-15-9 | Aloserton |
30 |
3-Ethoxy-4-methoxybenzaldehyde | 1131-52-8 | Apremilast |
31 |
3-Amino pthalic Acid HCL | 5434-20-8 | Apremilast |
32 |
3-Ethoxy-4-methoxy Benzonitrile | 60758-86-3 | Apremilast |
33 |
4-Tertiarybutylbenzene sulphonamide | 6292-59-7 | Bosentan |
34 |
2-(4-Nitrophenoxyethyl)chloride | 3383-72-0 | Dofetilide |
35 |
N-Methyl-4-nitrophenylethylamine.HCl | 166943-39-1 | Dofetilide |
36 |
3-(4-Hydroxyphenyl)propionic acid | 501-97-3 | Esmolol |
37 |
4-(2,4-Difluorophenyl)-4-oxobutanoic acid | 110931-77-6 | Posaconazole |
38 |
1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine | 74853-08-0 | Posaconazole |
39 |
(2E,4E)-(5-(4-Methoxy-2,3,6-trimethylphenyl) -3-methylpenta-2,4-dienyl)triphenyl phosphonium bromide |
54757-44-7 | Acitretin |
40 |
E-Butyl-3-methyl-4-oxobut-2-enoate | 54145-95-8 | Acitretin |
41 |
3-(3-Phenylsulfamoylphenyl)acrylic acid | 412269-00-2 | Belinostat |
42 |
Methyl-4-acetylbenzoate | 3609-53-8 | Micafunginm / Mycamine |
43 |
4-Morpholinoaniline | 2524-67-6 | Reversine |
44 |
3-Bromo-2-methylbenzoic acid | 76006-33-2 | Sonidegib |
45 |
4-Mercaptophenylacetic acid | 39361-84-7 | Sonidegib |
46 |
1-(4-Hydroxymethyl)phenylacetic acid | 73401-74-8 | Netrasudil |
47 |
1-Amino-2-methylindoline.Hydrochloride | 102789-79-7 | Indapamide |
48 |
4-Chloro-3-sulfamoylbenzoyl chloride | 70049-77-3 | Indapamide |
49 |
3-(2-Chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine.HCl | 69-09-0 | Chloropromazine |
50 |
2-Butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran | 1951-26-4 | Amiodarone |
51 |
6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 | Favipiravir |
52 |
(1R,4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol | 52154-82-2 | Cannabidiol |
53 |
Para-Menthadienol / (1R,4S)-1-Methyl-4-(prop-1-en-2-yl) cyclohex-2-enol |
22771-44-4 | Cannabidiol |
54 |
3-(4-Chlorophenyl)propionic acid | 2019-34-3 | Pitolisant |
55 |
3-(Piperidin-1-yl)propan-1-ol | 104-58-5 | Biperidene/ Cycrimine |
56 |
(R)-N-(2-(4-Isopropyl-4,5-dihydroxazol-2-yl) -6-methylphenyl)methane sulfonamide |
871360-40-6 | Eribuline |
57 |
4-(4-Nitrophenyl)butyric acid | 5600-62-4 | Chlorambucil |
58 |
5-(N,N-Dibenzylglycyl)salicylamide | 30566-92-8 | Labetalol |
59 |
3-cyano-4-isopropoxybenzoic acid | 258273-31-3 | Ozanimod |
60 |
4-bromobenzene sulfonyl chloride | 98-58-8 | Ozanimod |
61 |
4-chloro-3-nitro-5-sulfamoylbenzoic acid | 22892-96-2 | Bumetanide |
62 |
3-Nitro-4-phenoxy-5-sulfamoylbenzoic acid | 28328-53-2 | Bumetanide |
63 |
3-Amino-4-phenoxy-5-sulfamoylbenzoic acid | 28328-54-3 | Bumetanide |
64 |
3-(3, 4-Dihydroxyphenyl)propionic acid | 1078-61-1 | Dihydrocaffeic Acid |
65 |
1-(3,4-Dimethoxy-2-Nitrobenzyl)-2-methyl-1,2,3,4-Tetrahydro isoquinoline | 16472-50-7 | Apomorphine |
66 |
1,2,6,7-Tetrahydro-8H-indenofuran-8-one | 196597-78-1 | Ramelteon |
67 |
3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl) -5,6-dihydropyridin-2(1H)-one |
545445-44-1 | Apixaban |
68 |
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-03 | Apixaban |
69 |
Ethyl 3-Amino bennzoate | 582-33-2 | Tricaine Mesylate |
70 |
Sodium 4-Phenylbutyrate | 1716-12-7 | Sodium Phenylbuterate |
71 |
(R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine | 300543-56-0 | Levocitrazine |
72 |
Docusate Sodium | 577-11-7 | Docusate Sodium |
73 |
1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine | 39577-43-0 | Flupenthixol |
74 |
3-[10,10-Dimethyl-9(10H)-anthrylidene] -N,N-dimethylpropylamine hydrochloride |
10563-70-9 | Melitracen Dihydrochloride |
75 |
6-Chloro-1,3-dimethyluracil | 6972-27-6 | Urapidil |
76 |
1-[4-(Benzyloxy)phenyl]-2-bromopropan-l-one | 35081-45-9 | Isoxsuprine |
77 |
1-Phenoxypropan-2-amine | 35205-54-0 | Isoxsuprine |
78 |
1-(4-Benzyloxyphenyl)-2-[1-methyl-2-phenoxyethylamino] propanone HCL | 1860-67-9 | Isoxsuprine |
79 |
(1-[4-(1,1-Dimethyl ethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one | 97928-18-2 | Ebastine |
80 |
Methyl 2-oxocyclohexanecarboxylate | 10472-24-9 | Loxoprofen |
81 |
2-(4-Bromomethyl)Phenylpropionic Acid | 111128-12-2 | Loxoprofen |
82 |
2-{4-[(2-Oxocyclopentyl)methyl]phenyl}propanoic acid | 68767-14-6 | Loxoprofen |
83 |
2-(3-Methoxyphenethyl)phenol | 167145-13-3 | Sarpogrelate |
84 |
1-(Dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy] -2-propanol hydrochloride |
135261-74-4 | Sarpogrelate |
85 |
5-Nitro salicylic acid | 96-97-9 | Mesalamine |
86 |
Fenofibric Acid | 42017-89-0 | Choline Fenofibrate |
87 |
5-Chloro-2-Nitro Benzoic Acid | 2516-95-2 | |
88 |
2-[2-(3-Methoxyphenyl)ethyl]phenol | 167145-13-3 | |
89 |
4-Bromo-3-chloro benzaldehyde | 120077-69-2 | |
90 |
4-Bromo-3-chlorobenzoic Acid | 25118-59-6 | |
91 |
3-Bromo-1-propanol | 627-18-9 | |
92 |
2-Bromo-1-Phenyl Propane | 2114-39-8 | |
93 |
Methyl 3-piperidin-1-yl-propanoate | 23973-93-5 |
Pharmaceutical Intermediates - Under Development
S.No. |
NAME OF INTERMEDIATE | CAS NUMBER | API Application |
---|---|---|---|
1 |
2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one | 224789-21-3 | Vardenafil |
2 |
(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride | 521284-21-9 | Mirabegron |
3 |
4-Bromo Methyl Benzoate | 2417-72-3 | |
4 |
(1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-61-4 | Mirogabilin Besylate |
5 |
3-ethylbicyclo[3.2.0]hept-3-en-6-one | 12354-59-0 | Mirogabilin Besylate |
6 |
2-((1R,5S,6S)-6-(Aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid | 2166206-19-3 | Mirogabilin Besylate |
7 |
4,5-Dimethoxy-1-cyanobenzocyclobutane | 35202-54-1 | Ivabradine Hydrochloride |
8 |
(S)-1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine | 866783-12-2 | Ivabradine Hydrochloride |
9 |
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride | 866783-13-3 | Ivabradine Hydrochloride |
Note : Above products will NOT be supplied to countries in which these could be in conflict with existing patents. The final responsibility lies exclusively with the buyer.